Not applicableLooking for participantsNCT02419274What this trial is testingAdult Arm of DZL All Age Asthma Cohort (ALLIANCE)Who this might be right forAsthma LungenClinic Grosshansdorf 400
Testing effectiveness (Phase 2)Study completedNCT00476190What this trial is testingALL Adult Consortium Trial: Adult ALL TrialWho this might be right forAcute Lymphoblastic Leukemia Dana-Farber Cancer Institute 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497What this trial is testingAssess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Who this might be right forRelapsed or Refractory T-cell Lymphomas Bristol-Myers Squibb 85
Not applicableActive Not RecruitingNCT07150897What this trial is testingEarly Rehabilitation of Abdominal Muscle Wall Following Lower Transverse Abdominal IncisionWho this might be right forAll Participants Are Post Operative Women After Their 1st Cesarean Delivery or Hysterectomy Beni-Suef University 60
Early research (Phase 1)Active Not RecruitingNCT01430390What this trial is testingIn Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell MalignanciesWho this might be right forAcute Lymphocytic LeukemiaLymphoma Memorial Sloan Kettering Cancer Center 19
Not applicableStudy completedNCT03740022What this trial is testingACL Versus ALL + ACL StudyWho this might be right forAnterior Cruciate Ligament InjuryLigament Rupture Ascopharm Groupe Novasco 592
Not applicableUnknownNCT05873322What this trial is testingGlucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and LymphomaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes MellitusImpaired Glucose Tolerance+1 more Aarhus University Hospital 100
Not applicableNot Yet RecruitingNCT06763302What this trial is testingNGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALLWho this might be right forB Cell Precursor Acute Lymphoblastic LeukemiaPediatricMinimal Residual Disease+1 more The Children's Hospital of Zhejiang University School of Medicine 1,220
Large-scale testing (Phase 3)Ended earlyNCT02656329What this trial is testingInternational Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical DeviceWho this might be right forHeart Failure GE Healthcare 395
Not applicableLooking for participantsNCT06550687What this trial is testingStudy of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.Who this might be right forAll Types of Metastatic Solid Malignancy1st-line TreatmentExome Analysis+1 more Centre Georges Francois Leclerc 80
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Not applicableWithdrawnNCT04288193What this trial is testingImplementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot StudyWho this might be right forBehavioral and Psychiatric Symptoms of DementiaInsomnia Tabula Rasa HealthCare
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Testing effectiveness (Phase 2)UnknownNCT04714593What this trial is testingTargeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia, B-Cell Shanxi Province Cancer Hospital 24
Testing effectiveness (Phase 2)Study completedNCT02458014What this trial is testingBlinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual DiseaseWho this might be right forAdult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT06175221What this trial is testingAutologous TLPO Vaccine BasketWho this might be right forTumor, SolidTumor MetastasisCancer+1 more Elios Therapeutics, LLC 63
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03286634What this trial is testingASIA Down Syndrome Acute Lymphoblastic Leukemia 2016Who this might be right forDown SyndromeAcute Lymphoblastic LeukemiaChildhood Cancer National Hospital Organization Nagoya Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT00905398What this trial is testingNilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia Rony Schaffel 8